Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
AGY

Allergy Therapeutics plc

AGYLSEUnited KingdomHealthcareDrug Manufacturers - Specialty & GenericAIM

Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies,…more

P/B57.00xROIC-80.1%
£360.95M
Market Cap
EV: £366.73M
MOM3
QUAL3
VAL0
RSK10
AGY
£360.95M
Market Cap · EV £366.73M

Allergy Therapeutics plc

MOM3
QUAL3
VAL0
RSK10

Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies,…more

Latest RNS from Allergy Therapeutics plc

Analyst consensus: Buy

As of 20 Sept 2026, 1 analyst rate Allergy Therapeutics plc a Buy, with 100% buy ratings and a mean price target of 13p (range 13p–13p), +150% vs the current price.

Strong buy: 0Buy: 1Hold: 0Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies